Eli Lilly Co. (LLY) said its fourth-quarter reported net income stood at $915.4 million or $0.83 per share versus a loss of $3.63 billion or $3.31 per share in the comparable period.
Pro forma non-GAAP net income for the period declined to $999.4 million or $0.91 per share from $1.12 billion or $1.02 per share last year. On average, 18 analysts polled by Thomson Reuters expected earnings per share of $0.92 for the quarter. Analysts' estimate typically excludes one-time items.
In the fourth quarter of 2009, worldwide total revenue was $5.93 billion, an increase of 14% compared with $5.20 billion in the fourth quarter of 2008. Pro forma total revenue increased 13% to $5.93 billion from $5.26 billion a year earlier. Thirteen analysts estimated revenues of $5.66 billion for the quarter.
Excluding the potential impact of health care reform in the U.S., the company still anticipates 2010 earnings per share of $4.65 - $4.85 on both a reported and a non-GAAP basis. Twenty analysts estimate fiscal 2010 earnings per share of $4.73.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.